EUVIMEDEUVIMED entdecken
Crossref

Patterns of recurrence in HNSCC patients treated definitively with upfront surgery, chemoradiation

Pei Yuan Fong, Thomas Kwok Seng Loh, Liang Shen, Donovan Kum Chuen Eu, Chwee Ming Lim

European Archives of Oto-Rhino-Laryngology · 2024

DOI: 10.1007/s00405-024-08556-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2024. Verfasst von Pei Yuan Fong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Locally-advanced oropharynx (LA-OPSCC) and hypopharynx/larynx (LA-HPLSCC) cancers may be treated with surgical or non-surgical modalities. While survival outcomes are comparable, patterns of disease recurrence are not well established. METHODS: Retrospective review of 98 consecutive patients with LA-OPSCC or LA-HPLSCC treated by either surgery plus adjuvant therapy (S-POAT, n = 48) or chemoradiation (CRT, n = 50). RESULTS: CRT-treated patients had higher recurrence risk (42% vs 14.6%, p = 0.003). This was significant only among LA-OPSCC (p = 0.002) but not LA-HPLSCC patients (p = 0.159). Median time to recurrence in LA-OPSCC was 16.8 vs 11.6 months, and 16.6 vs 15.1 months in LA-HPLSCC, comparing surgically treated and CRT cohorts. Surgically-treated p16-negative LA-OPSCC experienced improved locoregional control than CRT-treated patients (100% vs 12.5%, p = 0.045) and 3-year RFS (83.0% vs 33.3%, p < 0.001). CONCLUSION: Locoregional control and RFS benefit was observed in surgically treated p16 negative LA-OPSCC patients. Locoregional recurrence is the main reason of treatment failure in LA-HNSCC, occurring commonly within the first 2 years post-treatment, regardless of treatment option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckNeoplasm Recurrence, LocalChemoradiotherapyRetrospective Studies

Stichwörter der Autor:innen

ChemoradiationHead and neckRecurrenceSquamous cell carcinomaSurgery

Autor:innen und Institutionen

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Otolaryngology- Head and Neck Surgery, National University Health System, 1E Kent Ridge Road, Level 7 NUHS Tower Block, Singapore, 119228, Singapore.
  • National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Otolaryngology- Head and Neck Surgery, National University Health System, 1E Kent Ridge Road, Level 7 NUHS Tower Block, Singapore, 119228, Singapore. donovan_eu@nuhs.edu.sg.
  • National University Cancer Institute, National University Health System, Singapore, Singapore. donovan_eu@nuhs.edu.sg.

Zitieren

APA

Fong, P. Y., Loh, T. K. S., Shen, L., Eu, D. K. C., & Lim, C. M. (2024). Patterns of recurrence in HNSCC patients treated definitively with upfront surgery, chemoradiation. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-08556-6

Vancouver

Fong PY, Loh TKS, Shen L, Eu DKC, Lim CM. Patterns of recurrence in HNSCC patients treated definitively with upfront surgery, chemoradiation. European Archives of Oto-Rhino-Laryngology. 2024. doi:10.1007/s00405-024-08556-6

BibTeX
@article{Fong2024,
  author = {Fong, Pei Yuan and Loh, Thomas Kwok Seng and Shen, Liang and Eu, Donovan Kum Chuen and Lim, Chwee Ming},
  title = {Patterns of recurrence in HNSCC patients treated definitively with upfront surgery, chemoradiation},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2024},
  doi = {10.1007/s00405-024-08556-6}
}
Kostenlos starten →